HBM Pharma/Biotech M&A Report
HBM Partners carries out an ongoing analysis of all trade sales of public and private US and European biotech and pharma companies. The report covers all completed trade sales of North American (US and Canada) and European biotechnology, specialty pharma, generics, OTC and “traditional” pharma companies since 2005. While providing some top line results for public and private transactions, the analysis focuses mainly on trade sales of private venture- or private-equity-backed companies (called “VC/PE-backed companies” in this report).
In addition to the reports, you can also download the list of all the transactions in an excel file so you could sort the data any way you want.